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Abstract
Purpose Watercress is a rich source of phytochemicals with anticancer potential, including phenethyl isothiocyanate (PEITC). 
We examined the potential for watercress extracts and PEITC to increase the DNA damage caused by ionising radiation (IR) 
in breast cancer cells and to be protective against radiation-induced collateral damage in healthy breast cells. The metabolic 
events that mediate such responses were explored using metabolic profiling.
Methods 1H nuclear magnetic resonance spectroscopy-based metabolic profiling was coupled with DNA damage-related 
assays (cell cycle, Comet assay, viability assays) to profile the comparative effects of watercress and PEITC in MCF-7 breast 
cancer cells and MCF-10A non-tumorigenic breast cells with and without exposure to IR.
Results Both the watercress extract and PEITC-modulated biosynthetic pathways of lipid and protein synthesis and resulted 
in changes in cellular bioenergetics. Disruptions to the redox balance occurred with both treatments in the two cell lines, 
characterised by shifts in the abundance of glutathione. PEITC enhanced the sensitivity of the breast cancer cells to IR 
increasing the effectiveness of the cancer-killing process. In contrast, watercress-protected non-tumorigenic breast cells 
from radiation-induced damage. These effects were driven by changes in the cellular content of the antioxidant glutathione 
following exposure to PEITC and other phytochemicals in watercress.
Conclusion These findings support the potential prophylactic impact of watercress during radiotherapy. Extracted compounds 
from watercress and PEITC differentially modulate cellular metabolism collectively enhancing the therapeutic outcomes 
of radiotherapy.
Keywords Breast cancer · Metabolomics · Phenethyl isothiocyanate · Radiotherapy · Watercress
Abbreviations
IR  Ionising radiation
NMR  Nuclear magnetic resonance
OPLS-DA  Orthogonal projections to latent structures-
discriminant analysis
PCA  Principal component analysis
PEITC  Phenethyl isothiocyanate
Q2Y  Predictive ability parameter of OPLS-DA 
model
WX  Watercress
Introduction
Breast cancer is a leading cause of cancer-related mortalities 
globally. Over 266,000 new breast cancer cases are projected 
to occur solely in the United States in 2018 accounting for 
over 40,000 deaths [1]. In the United Kingdom, breast can-
cer is the most common type of cancer in women, with 
nearly 53,700 new cases in 2013 and a one in eight estimated 
lifetime risk of diagnosis [2]. Radiotherapy is a primary 
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treatment modality for breast cancer patients. This approach 
uses the fractionated delivery of high-energy X-ray beams to 
generate highly reactive free radicals in target tumour tissue. 
This causes DNA damage via lipid peroxidation or oxidative 
cellular respiration. Radiation-induced damage activates sev-
eral signal transduction pathways whose primary role is to 
detect genomic injury leading to cell cycle arrest and DNA 
repair. In the event of substantial damage, the endogenous 
apoptotic machinery of the cells is triggered to inhibit fur-
ther replication of the damaged DNA [3]. Radiotherapy also 
causes damage in healthy cells and can potentially trigger 
new cancer-initiating DNA mutations in local tissue. Thera-
peutic selectivity is, therefore, a vital issue in cancer therapy, 
and an ideal anticancer agent should be toxic to cancerous 
cells but exert minimal toxicity in healthy cells.
Watercress (Nasturtium officinale) belongs to the fam-
ily of Brassicaceae together with broccoli, brussels sprouts 
and kale. Epidemiological studies suggest a link between 
the consumption of Brassica vegetables and a reduced risk 
for many types of cancers [4] including breast cancer [5, 6]. 
Watercress has a complex phytochemical profile character-
ised by high amounts of carotenoids, flavonols and glucosi-
nolates [7] and is the main dietary source of phenethyl iso-
thiocyanate (PEITC). Crude extracts of watercress have been 
shown to demonstrate strong antioxidant capacity in vitro 
[8, 9] and have been associated with the inhibition of the 
three stages of carcinogenesis: initiation, proliferation and 
metastasis in in vitro cancer cell models [10–12].
PEITC has been extensively shown to have direct antican-
cer effects in in vitro cancer models. PEITC exists in water-
cress as gluconasturtiin before mastication of the leaves, 
which exposes the parent compound to myrosinase resulting 
in the production of PEITC. It causes cell cycle arrest and 
mitochondrial damage in a wide variety of cell lines and it is 
a potent inducer of apoptosis [13–16]. Combined treatment 
of cancer cells with PEITC and established chemotherapeu-
tic agents such as cisplatin and doxorubicin potentiates their 
cancer-killing properties [17, 18]. These findings support the 
potential of PEITC to be used as an adjuvant treatment dur-
ing radiotherapy in cancer patients. Due to its highly elec-
trophilic nature PEITC reacts with cellular thiols such as 
glutathione, the major intracellular antioxidant, depleting the 
cells of their antioxidant content and impacting cell survival 
[13, 19, 20]. As radiotherapy works primarily by inducing 
DNA damage through the formation of free radicals, the 
ability of PEITC to deplete the radical scavenger glutathione 
is likely to contribute to its radio-sensitising properties.
Metabolic regulation is a determining factor of the cell 
growth machinery and cancer cells have adapted to several 
oncogenic signals to modify their metabolic phenotype 
to support their needs for growth, survival and malignant 
transformation [21]. To our knowledge, limited work has 
been performed on the effects of isothiocyanates or of crude 
watercress extract on cancer cell energetics and metabolism. 
In this work, a metabolic profiling approach has been used to 
study the biochemical response of MCF-7 breast cancer cells 
and immortalised but non-tumorigenic MCF-10A cells to 
increasing doses of watercress extract (lacking PEITC) and 
PEITC alone. The impact of PEITC or watercress extract on 
the biomolecular events exerted by X-ray irradiation expo-
sure was then investigated in these breast cells. Combining 
high-resolution metabolic phenotyping with measures of cell 
viability and DNA damage enables the radio-sensitising or 
radio-protective potential of watercress and its components 
to be evaluated.
Materials and methods
Cell culture
The MCF-7 human breast adenocarcinoma cell line was pur-
chased from the American Type Culture Collection (ATCC) 
(LGC standards, Middlesex, UK). Cells were cultured in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% (v/v) foetal bovine serum, 2 mM glu-
tamine, 50 U/ml penicillin and 50 U/ml streptomycin and 1% 
non-essential amino acids. The MCF-10A, non-tumorigenic 
breast epithelial cell line was purchased from ATCC (LGC 
standards, Middlesex, UK). Cells were maintained in Ham’s 
F12:DMEM (1:1), 20 ng/ml epidermal growth factor (EGF) 
(PeproTech, London, UK), 0.1 µg/ml cholera toxin, 10 µg/
ml insulin, 500 ng/ml hydrocortisone, 5% horse serum and 
50 U/ml penicillin and 50 U/ml streptomycin.
Treatments and irradiation
For the watercress extract, fresh watercress samples were 
obtained directly from Vitacress Salads Ltd. (Andover, UK). 
Samples were snap frozen in liquid nitrogen and stored 
at − 80 °C. 2 g of leaf and 2 g of stem were weighed and 
placed in a 20 ml syringe that had the plunger removed and 
a circular 25 mm glass microfiber filter placed at the bot-
tom. The syringe was then placed inside a 50 ml centrifuge 
tube without the lid and centrifuged at 1500g for 30 min to 
collect the extract. This crude watercress extract was then 
filtered through a 0.22 µm filter and used in the cultures. 
Phytochemical characterisation of the watercress extract 
has previously been published [7]. As PEITC is produced 
after consumption following exposure to myrosinase, it is 
absent from the watercress extract. To examine the meta-
bolic effects of PEITC, 30 mM of PEITC was made up in 
DMSO fresh on the day of use. MCF-7 and MCF-10A cells 
were seeded at 1 × 105 cells per well into six well plates and 
treated at 80% confluence. Cells were exposed to the water-
cress extract at 6.25, 12.5, 25 and 50 µl/ml and PEITC at 5, 
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10, 20, 30 µM for 24 h. Following the watercress extract/
PEITC treatment period, the cells were exposed to 5 Gy 
X-ray radiation using an orthovoltage X-ray unit (Gulmay 
Medical D3225, Xstrahl, UK). The irradiator was at a sta-
ble distance from the cell culture plates and the irradiator 
field was approximately 20 × 20 cm. The cell culture plates 
were placed in the centre of the irradiation field. Following 
radiation treatment cells were returned in the incubator and 
were allowed to rest for 1 h. The cells were then collected 
and used in the experiments.
Cell proliferation and viability
DAPI staining
For the determination of cell proliferation MCF-7 and MCF-
10A cells were seeded in 96-well microplates at 5 × 103 
cells per well and incubated at 37 °C with 5%  CO2 and 95% 
humidity for 24 h. Cells were exposed to the respective treat-
ments and then permeabilized with 100 µl of ice-cold metha-
nol for 5 min at room temperature. Methanol was removed 
and the plates were allowed to air-dry for 15 min in a hood, 
followed by addition of 100 µl of DAPI in PBS (70 µl of 
30 mM DAPI stock solution in 10.43 ml of PBS). Cells were 
incubated in the dark for 30 min at 37 °C and absorption was 
measured using GENios microplate reader (TECAN Group 
Ltd., Mannedorf, Switzerland) with absorbance at 340 nm 
and emission at 465 nm. The experiment was performed 
in triplicate with three technical replicates per experiment.
MTT assay
Cell viability was assessed using the MTT [3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide]-based 
in vitro toxicology assay kit (Sigma–Aldrich, Dorset, UK) 
according to the manufacturer’s instructions, in the case of 
the irradiation experiments. The experiment was performed 
in triplicate with three technical replicates per experiment.
1H NMR spectroscopy‑based metabolic phenotyping
The metabolic profiles of MCF-7 and MCF-10A cells were 
measured using 1H NMR spectroscopy. Cells were seeded 
and treated as described above. Media was transferred 
into Eppendorf tubes and cells on the surface of the plate 
were washed twice using 1 ml of cold (4 °C) PBS and were 
quenched using 1 ml of ice-cold methanol (maintained on 
dry ice). Cells were allowed to lyze for 2 min and were 
detached from the plate using a cell scraper and transferred 
into an Eppendorf tube. Methanol quenching was repeated 
to maximize metabolite recovery. A vacuum concentra-
tor (SpeedVac) was used to dry down the cell suspensions 
before reconstitution in 80 µl of phosphate buffer (pH 7.4) 
in 100% deuterium oxide containing 1 mM of the internal 
standard, 3-(trimethylsilyl)-[2,2,3,3,−2H4]-propionic acid 
(TSP).
For every sample, a standard one-dimensional NMR 
spectrum was acquired using a 600 MHz Bruker NMR spec-
trometer, with water peak suppression using a standard pulse 
sequence [recycle delay (RD)-90°-t1–90°-tm-90°-acquire free 
induction decay (FID)]. For each spectrum, 256 scans and 
8 dummy scans were obtained, collected in 64K data points 
with a spectral width of 12.001 ppm. 1H NMR spectra were 
manually corrected for phase and baseline distortions and 
referenced to the TSP singlet at δ 0.0. Spectra were dig-
itised using in-house Matlab (version R2016a, The Math-
works, Inc.; Natwick, MA) scripts. Metabolites were identi-
fied using an in-house database of standards. Multivariate 
modelling, including principal component analysis (PCA) 
and orthogonal projections to latent structure discriminant 
analysis (OPLS-DA), were performed using in-house scripts 
in Matlab.
Cell cycle
Watercress extract and PEITC-treated MCF-7 and MCF-10A 
cells were collected by centrifugation and were then fixed 
in 70% (v/v) fresh ice-cold ethanol. The samples were then 
stored at − 20 °C until analysis. For the analysis, samples 
were centrifuged and the cell pellets were resuspended in 
200 µl of PBS and 25 µl of 1 mg/ml RNAse added to the sus-
pensions. The samples were incubated at 37 °C for 30 min 
and 2.5 µl of 400 µg/ml of propidium iodide dye were added 
to the cells which were then incubated for a further 30 min at 
room temperature under dark conditions. The final volume 
of the cell suspensions was adjusted to 600 µl with PBS. 
Cellular DNA content of 15,000 cells was quantified via 
flow cytometry. The flow cytometry analysis was performed 
using the FL2 channel on a BD Accuri™ C6 flow cytometer 
(Germany). Data analysis was facilitated using the Flow Jo 
software (version 7.6, Tree star Inc, Oregon, USA). Cell 
cycle progression was evaluated accounting for the percent-
age of all cells in each of the phases (G1, S, G2/M).
Comet assay
The Comet assay was used for the measurement of DNA 
strand breaks in single cells. Treated cell suspensions were 
adjusted to a concentration of 1 × 106 cells/ml and 50 µl were 
resuspended in 85 µl of warm low-melting point agarose 
(0.85% w/v) and applied on Trevigen Comet slides. The 
slides were allowed to solidify at 4 °C for 10 min. The slides 
were then transferred into a staining jar, lysis buffer was 
added (2.5 M NaCl, 0.1 M EDTA, 0.01 M Tris and 1% (v/v) 
Triton X—added just prior to use—pH 10), and the cells 
were lysed for 1 h at 4 °C. Following lysis of the cells, the 
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slides were placed in a horizontal electrophoresis tank and 
incubated for 20 min in alkaline buffer (0.3 M NaOH, 1 mM 
EDTA—pH 13) at 4 °C in dark conditions. Subsequent to 
DNA unwinding, electrophoresis was carried out at 26 V, 
300 mA for 20 min at 4 °C. Immediately after electropho-
resis, the slides were washed in neutralising buffer (0.4 M 
Tris—pH 7.5) three times for 5 min. Slides were stained 
with ethidium bromide (20 µl/ml) and DNA migration from 
the nucleus was visualised with a fluorescence microscope 
(Olympus BX51). The computer-based image analysis soft-
ware, Komet 4.0 (Andor Technology, South Windsor, CT) 
was used to calculate % tail DNA, the proportion of DNA 
migrated from the head to the tail of the comet. The mean 
value from 75 randomly scored cells was taken as an index 
of damage for each replicate well.
Results
Cell proliferation and viability
Impact on cell proliferation of increasing doses of the crude 
watercress extract and PEITC was assessed in MCF-7 (wild 
type p53) and MCF-10A cells. The dose response curves for 
proliferation as assessed by DAPI staining are presented in 
Fig. 1a–d. Watercress extract treatment did not alter MCF-
10A proliferation but caused a 20% and 25% decrease in pro-
liferation in MCF-7 cells treated with 25 and 50 µl/ml of the 
extract, respectively. PEITC caused a significant decrease in 
cell proliferation in MCF-7 cells reaching up to 46% inhibi-
tion at the highest PEITC dose (30 µM). Treatment of the 
MCF-10A cells with PEITC showed evidence of inhibition 
of proliferation only at the highest dose (30 µΜ).
The combination of PEITC or watercress treatment 
and IR on the overall metabolic activity of the cells was 
assessed using the MTT assay as a proxy of viable, meta-
bolically active cells. Although there was a trend for IR to 
decrease mean reducing activity in both cell lines, this was 
not statistically significant (p > 0.05). Significant decreases 
in the metabolic activity of both cell lines were observed 
with PEITC pre-treatment prior to IR (Fig. 1e, f). At 20 µM, 
PEITC enhanced the effects of IR on cell viability reducing 
cell viability by 86% in MCF-7 (p < 0.01) and 69% in MCF-
10A (p < 0.05) relative to IR alone. 10 µM of PEITC did not 
affect MCF-10A cell viability.
Exposure to the watercress extract prior to IR did not have 
an impact on cell viability in MFC-10A cells compared to 
irradiated cells. Combined exposure to watercress and IR 
resulted in significant decrease in cell viability of MCF-7 
cells in both 12.5 µl/ml (41%) and 50 µl/ml (53%) compared 
to the non-irradiated controls (p < 0.01).
Cell cycle
At the basal level, untreated MCF-7 cells had 10% greater 
cell distribution in the S phase and 8% in the G2 phase 
compared with untreated MCF-10A cells. In MCF-7 cells 
(Fig. 2a), the watercress extract (50 µl/ml) caused a signifi-
cant 11% reduction in the G1 phase and a parallel increase 
in the proportion of the cells in the S phase. PEITC induced 
a cell cycle arrest at the G1 phase only at the highest doses 
(13% and 16% increase respectively) with a concomitant 
decrease in the proportion of cells in the S phase (39 and 
34% decrease at 20 µM and 30 µM respectively) compared to 
non-treated cells (Fig. 2b). A similar effect of the watercress 
extract was observed with the MCF-10A cells with an 8% 
reduction of cells in the G1 phase and a 4% increase of cells 
in the S phase (50 µl/ml) (Fig. 2c). In contrast, PEITC did 
not induce a cell cycle arrest at the G1 stage as observed in 
the MCF-7 cells. PEITC caused a significant increase in the 
percentage of MFC-10A cells in the S (20 µM: 21%, 30 µM: 
18% increase) and G2 phase (20 µM: 94%, 30 µM: 118% 
increase) and a concomitant decrease of the cells in the G1 
phase only at the two highest doses (Fig. 2d).
MCF-7 cells responded to IR treatment with an accu-
mulation of cells in G2 arrest coupled to a decrease in the 
number of cells in S phase. In contrast the MCF-10A cells 
responded to IR by increasing the proportion of cells in the 
G1 phase of the cell cycle (~ 6%) (Fig. 2e, f) coupled to an 
11% reduction in the percentage of cells in G2.
Pre-treatment of MCF-7 and MCF-10A cells with the 
watercress extract or with PEITC differentially sensitised 
cells to a subsequent dose of 5 Gy IR, (Fig. 2e, f). In the 
MCF-7 cells, pre-treatment with PEITC (20 µM) led to 
a further reduction in the number of irradiated cells in S 
phase, and an accumulation of irradiated cells in G1 cell 
cycle arrest with a reduction in the proportion of cells in G2 
relative to non-pretreated irradiated controls. The same dose 
of PEITC alone caused a 7.6% increase in the proportion of 
the cells in G1 phase but when combined with IR the pro-
portion increased to 18.4% (Fig. 2g). In the MCF-10A cells, 
PEITC caused a minor decrease in the proportion of the cells 
on the G2 phase coupled to an increase in the percentage of 
the cells in the S phase.
In contrast to PEITC, watercress increased the percentage 
of IR cells in S phase in both cell lines. In the MCF-7 cells, 
this was coupled to a decrease in the proportion of cells in 
G2, whereas in the MCF-10A cells the proportion of cells 
in G1. These observations were not seen in non-irradiated 
watercress-treated cells.
Comet assay
To further assess if the observed cell cycle arrest was a 
response to DNA damage, DNA lesions were quantified 
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using the Comet assay. MCF-7 and MCF-10A cells were 
treated with PEITC or the watercress extract for 24 h and 
exposed to 5 Gy of IR or control treatment. A mild difference 
in basal DNA damage was observed between MCF-10A 
cells (8.8 ± 1.4%) and MCF-7 cells (13.6 ± 1.6%) (Fig. 3a–c). 
Crude watercress extract did not induce any significant 
Fig. 1  Cytotoxicity of the crude watercress extract and PEITC in 
MCF-7 (a, b) and MCF-10A (c, d) cells. Effect of PEITC and water-
cress extract (WX) pre-treatment (24  h) combined with 5  Gy of IR 
on MCF-7 (e) and MCF-10A (f) cell proliferation. Data presented 
as mean ± SEM percentage cell survival. Statistically significant dif-
ferences between control and treated cells are indicated *p < 0.05, 
**p < 0.01, ***p < 0.001 (a–d), ##p < 0.01, ###p < 0.01 for compari-
sons to ‘Control−IR’ *p < 0.05, **p < 0.01 for comparisons to ‘Con-
trol + IR’ (e–f) after one-way ANOVA followed by Dunnett’s multiple 
comparison test. Data shown represent the average of three independ-
ent experiments with three replicates per sample. WX watercress
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Fig. 2  Cell cycle analysis of MCF-7 (a, b) and MCF-10A (c, d) 
exposed to a range of crude watercress extracts (0–50  µl/ml) and 
PEITC (0–30  µΜ) for 24  h, MCF-7 (e) and MCF-10A (f) cells 
exposed to 5  Gy of IR following a 24  h pre-treatment with PEITC 
or crude watercress extract (g). % Distribution of MCF-7 cells in G1 
upon treatment with PEITC or IR. Different letters suggest statistical 
significance (p < 0.05). Data presented as mean ± SEM percentage 
cell distribution. Statistically significant differences between control 
and treated cells are indicated *p < 0.05, **p < 0.01, ***p < 0.001 (a–
d), ##p < 0.01, ###p < 0.01 for comparisons to ‘Control − IR’ *p < 0.05, 
**p < 0.01 for comparisons to ‘Control + IR’ (e–f) after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown 
represent the average of three independent experiments with three 
replicates per sample. WX watercress
European Journal of Nutrition 
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Fig. 3  Genotoxic effects of the crude watercress extract and PEITC 
on MCF-7 (a, b) and MCF-10A (c, d) cells after a 24-h incubation. 
DNA damage levels in MCF-7 (e) and MCF-10A (f) cells exposed 
to 5  Gy of IR following 24  h pre-treatment with PEITC or crude 
watercress extract. Data presented as mean ± SEM percentage %tail 
DNA. Statistically significant differences between control and treated 
cells are indicated *p < 0.05, **p < 0.01, ***p < 0.001, after one-way 
ANOVA followed by Dunnett’s multiple comparison test. Data shown 
represent the average of three independent experiments with three 
replicates per sample. WX watercress
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genotoxic effects in either cell line at any of the concentra-
tions tested (Fig. 3a–c). In contrast, PEITC was genotoxic in 
both cell lines at 20 µM with significantly increased % tail 
DNA. At 20 µM, PEITC caused 14.1% additional damage 
in MCF-7 cells and 4.7% additional damage in MCF-10A 
cells (Fig. 3b–d).
IR treatment induced a 39% increase in tail DNA in 
MCF-7 cells and pre-treatment with 20 µM of PEITC sig-
nificantly increased the damage by a further 15% resulting 
in a final 66% tail DNA content (Fig. 3e). Pre-exposure of 
the MCF-7 cells to 50 µl/ml of the watercress extract also 
increased DNA damage by an additional 7% compared with 
the irradiated only cells.
MCF-10A cells exhibited sensitivity to IR (11% increase 
in tail DNA) but to a lesser extent than the cancerous MCF-7 
cells (39% tail DNA). A 24 h pre-treatment with 10 µM 
of PEITC and 50 µl/ml of watercress extract reduced the 
Comet tail from 19.37% in the irradiated cells to 13.88 and 
10.5%, respectively. The highest dose of PEITC combined 
with 5 Gy of IR was genotoxic to the non-tumorigenic cells 
resulting in a final 44% tail DNA (Fig. 3f).
Comparative metabolic profiling of MCF‑7 
and MCF‑10A cells
Metabolic profiles were acquired from the hydrophilic meth-
anol extracts of MCF-7 and MCF-10A cells using 1H NMR 
spectroscopy. An orthogonal projection to latent structures 
discriminant analysis (OPLS-DA) model was built for a 
pair-wise comparison between the two cell lines. An OPLS-
DA model with strong predictive ability (Q2Y = 0.56) was 
obtained and validated by permutation testing (1000 per-
mutations; p = 0.001). The correlation coefficients plot from 
this model is presented in Fig. S1a. MCF-7 cells contained 
greater amounts of glutathione, as well as the amino acids 
alanine, glutamine, methionine, threonine and glycine, lac-
tate, phosphocholine and glycerophosphocholine. MCF-10A 
cells contained greater amounts of leucine, valine, acetate, 
glutamate, aspartate, creatine, creatine phosphate, choline, 
glucose taurine, myo-inositol, the aromatic amino acids phe-
nylalanine and tyrosine compared to the MCF-7.
Comparative metabolic impact of IR in MCF‑7 
and MCF‑10A cells
Comparing the metabolic profiles of irradiated MCF-7 and 
MCF-10A cells returned a significant OPLS-DA model 
(Q2Ŷ = 0.90, p = 0.001) (Fig. S1b). Following irradiation, the 
metabolic differences between the cell types were observed 
with a greater abundance of lactate, alanine, glutamine, and 
glycine in the irradiated MCF-7 cells compared to irradiated 
MCF-10A cells. However, analysis of metabolic associations 
(correlation coefficients) summarised in Fig. 4a identified a 
substantial shift in glutathione between the two cell lines. 
At baseline, MCF-7 cells contained higher amounts of glu-
tathione compared to MCF-10A cells but post IR, this was 
reversed with MCF-10A cells containing higher glutathione. 
In addition, MCF-10A cells had lower amounts of phospho-
choline pre-IR compared to MCF-7 cells, but this difference 
was no longer significant post IR suggesting a higher phos-
phocholine utilization rate by the non-tumorigenic cell line 
upon IR exposure.
Metabolic effects of watercress and PEITC in MCF‑7 
and MCF‑10A cells
Unsupervised hierarchical clustering of the metabolite 
peak integrals was performed to elucidate the metabolic 
shifts induced in the two cell lines following 24-h treatment 
with increasing concentrations of the watercress extract or 
PEITC. The results are summarized in Fig. 5a, b. Clear met-
abolic variation can be seen across the treatments and doses 
in the MCF-7 cells. A different biochemical response to the 
treatments was observed in the MCF-10A cells. At the low 
doses (5, 10 µΜ), PEITC induced no observable metabolic 
alterations in the MCF-10A cells. In the MCF-7 cells, water-
cress and PEITC treatments induced contrasting metabolic 
responses. Glutathione, aspartate, glycine, phosphocholine 
and alanine were significantly reduced in the MCF-7 cells 
treated with higher doses of PEITC but were increased in the 
watercress extract-treated cells. The amino acids, threonine, 
glutamine, methionine, tyrosine, phenylalanine, leucine, iso-
leucine, valine and histidine, were all elevated in the PEITC-
treated MCF-7 cells and reduced in the watercress-treated 
groups. A more uniform response to watercress and PEITC 
exposure was observed in the MCF-7 cells compared to the 
MCF-10A cells.
Metabolic perturbations induced by IR combined 
with PEITC or watercress extract pre‑treatment
Figure 4b summarizes the metabolic response of each cell 
type to watercress or PEITC treatment and exposure to IR. 
Changes in cellular glutathione content were the most strik-
ing metabolic changes. A biphasic response of MCF-7 to 
PEITC doses with regards to glutathione was observed. Low 
PEITC exposure (10 µM) increased the glutathione content 
of MCF-7 cells but at the high PEITC dose (20 µΜ) glu-
tathione was depleted. This effect of PEITC in MCF-7 cells 
persisted after exposure to IR. In MCF-10A cells, PEITC 
increased glutathione at both low and high doses, but glu-
tathione was significantly decreased after exposure of the 
PEITC pre-treated cells to IR. Crude watercress extract treat-
ment alone, caused an increase in glutathione in MCF-7 cells 
and this effect persisted following IR. In contrast, a reduc-
tion in glutathione was seen in MCF-10A cells following 
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watercress treatment but was elevated when IR followed 
the watercress treatment. Most of the metabolic changes 
induced by the watercress extract and PEITC treatment per-
sisted after exposure to IR in both cell types. It should also 
be noted, that the metabolic signature of the MCF-10A cells 
pre-treated with the high PEITC dose (20 µM) followed by 
IR exposure, is suggestive of a metabolic shut-down in these 
cells. This is characterised by the depletion of most of the 
metabolites. The metabolic pathways influenced by IR com-
bined with PEITC or the watercress treatment in each of the 
cell lines are depicted in Fig. 6.
Discussion
This study combined in vitro experiments with high-reso-
lution metabolic phenotyping to show that watercress and a 
derivative of watercress, PEITC, can enhance the outcomes 
of radiotherapy via different molecular mechanisms. The 
protective effect of watercress in healthy cells observed here 
is unlikely to be a result of PEITC or any other isothiocy-
anate since they are not present in the extract, as a result of 
the high volatility of these compounds as well as the snap 
freezing of the plant material, which inactivates the myrosi-
nase enzyme that converts the glucosinolate precursor to the 
reactive isothiocyanate. As such, PEITC was absent from 
the watercress extract and its effects were studied indepen-
dently. Both the extract and PEITC were found to modulate 
the metabolome of healthy and cancerous breast cells, influ-
encing phospholipid and amino acid metabolism as well as 
modulating the energy and antioxidant status of these cells. 
These perturbations occurred alongside cell cycle arrest, 
DNA damage and compromised cell viability in cancerous 
cells. Subsequently, it was shown that through its ability to 
deplete glutathione, PEITC sensitizes breast cancer cells to 
radiation-induced damage, whereas the watercress extract 
protected healthy cells from IR toxicity by increasing intra-
cellular glutathione.
Baseline metabolic variation was clear between the 
cancerous MCF-7 cell line and the non-transformed MCF-
10A cell line. Greater lactate content in the cancerous cells 
reflects a higher rate of glycolysis in these cells for energy 
generation, consistent with the Warburg effect. MCF-7 cells 
also contained greater amounts of glutamine, an amino 
acid required for protein and nucleotide synthesis. Simi-
larly, phosphocholine was present in higher amounts in the 
MCF-7 cells, relative to the non-transformed cells, and likely 
relates to the higher proliferation rate in these cells and the 
increased synthesis of new cellular membranes, reflected in 
the higher proportion of cells in the S phase of the cell cycle 
Fig. 4  a Summary of the significant metabolic alterations identi-
fied from the OPLS-DA models comparing metabolic profiles of 
MCF-7 and MCF-10A cells with (+ IR) and without (− IR) radiation 
exposure (n = 5–6). Colours indicate the correlation coefficient (r) 
extracted from the OPLS-DA model. Red indicates metabolites that 
are present in higher amounts in MCF-10A cells and blue indicates 
metabolites that are present in lower amounts in MCF-10A cells com-
pared to MCF-7 cells. b Summary of the metabolites associated with 
the OPLS-DA models given by the correlation coefficient (r) with the 
response variable, in this case PEITC or watercress (WX) treatment 
and IR (n = 5–6) in comparison to non-irradiated control or irradiated 
control cells. The red colour indicates metabolites that are positively 
correlated with the respective treatment (PEITC or WX) and blue 
colour indicates a negative correlation between metabolites and treat-
ment
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compared with the MCF-10A cells. The cancerous cells also 
contained greater amounts of glutathione compared to the 
healthy cells. Glutathione serves as an intracellular antioxi-
dant and its increased abundance facilitates the maintenance 
of appropriate cellular redox status by keeping the amount 
of ROS at a level that enables cell proliferation and suc-
cessful progression through survival pathways as a result of 
post-translational modifications [22, 23]. Conversely, if the 
levels of ROS become extremely high this causes detrimen-
tal oxidative stress via macromolecular damage, senescence 
[24] and loss of mitochondrial membrane potential leading 
to apoptosis [25]; a collection of events that can have lethal 
effects on cells. To counter the outcomes of oxidative stress, 
cancer cells increase their antioxidant content (mainly glu-
tathione), limiting the accumulation of ROS at excessively 
high levels preventing irreparable damage [26]. Naturally, 
proliferating cells acquire oncogenic mutations, which 
favour anomalous energy metabolism and protein translation 
leading to aberrantly increased ROS [27]. Through further 
mutations and adjustments, cancer cells tightly orchestrate 
the cycling of ROS and antioxidant production in a manner 
that permits cell survival and maintenance of ROS at moder-
ate quantities.
Radiotherapy is an important treatment modality in breast 
cancer. This approach generates reactive free radicals, which 
damage DNA, ultimately resulting in cell death. Cancer cells 
posses several aberrant signalling pathways that can result in 
drug resistance or failure of therapeutic outcomes. Current 
research suggests that combination therapy can kill cancer 
cells more efficiently via diverse mechanisms simultane-
ously [28]. Isothiocyanates, such as PEITC, have a range of 
cellular targets for cancer-related outcomes, including cell 
cycle arrest, apoptosis, and anti-angiogenic effects [28]. As 
such, PEITC and its dietary source watercress are an attrac-
tive option for combinatorial therapeutic methods.
In the cancerous MCF-7 cells, IR caused DNA damage 
that resulted in G2 cell cycle arrest but there was no signifi-
cant impact on cell survival suggesting a potential resistance 
of these cells to IR killing. Our results are consistent with 
those of Jänicke et al. [29] who observed the same cell cycle 
arrest and failure of IR to activate the mitochondrial intrin-
sic apoptosis pathway. However, pre-treatment with PEITC 
resulted in significant G1 arrest parallel to increased DNA 
damage and a significant loss of cell viability. This is likely 
mediated by the ability of PEITC to induce p53 activity in 
MCF-7 cells [30], which is a potent regulator of G1 cell 
cycle arrest. PEITC can also induce apoptosis from the mito-
chondria in breast cancer cells by caspase activation, as well 
as changes in the Bac/Bcl-2 ratio following the release of 
cytochrome c, all significant elements of the intrinsic apop-
totic pathway [31]. In contrast, lower DNA damage was seen 
in the MCF-10A cells following PEITC and IR exposure.
Differences in glutathione content between MCF-7 and 
MCF-10A cells may contribute to the variation seen in 
response to PEITC and IR. Consistent with other studies, 
treatment of MCF-7 cells with IR-depleted intracellular glu-
tathione [32–34]. In contrast, MCF-10A cells responded to 
IR induced stress by increasing their glutathione content. IR 
generates ROS, which are quenched in part through the glu-
tathione response reducing the potential of ROS to exert oxi-
dative DNA damage. Elevations in intracellular glutathione 
in MCF-10A cells can be considered part of a protective 
response by upregulating the metabolic antioxidant capacity 
of these cells. This may explain their ability to better recover 
from IR-induced damage compared to MCF-7 cells and may 
explain the lower DNA damage observed in the healthy cells 
in this study.
PEITC appears to induce a biphasic response in the glu-
tathione abundance of MCF-7 cells, with increased concen-
trations at low doses and depletion at the two higher doses. 
The ability of isothiocyanates to act as both pro-oxidants 
and indirect antioxidants may explain these dose-depend-
ent fluctuations. Prolonged exposure to low isothiocyanate 
concentrations can induce phase II enzymes that regulate 
antioxidant gene expression [35], increasing glutathione 
synthesis and abundance. However, at higher doses PEITC 
depletes cells of glutathione through sustained intracellu-
lar conjugation and efflux [19, 20]. Glutathione depletion 
accompanied by compromised mitochondrial function ulti-
mately results in excessive oxidative stress, as demonstrated 
by increased DNA damage with higher PEITC exposure and 
may explain the observed cell cycle arrest and cell cytotox-
icity in MCF-7 cells treated with PEITC. Thus, the ability 
of PEITC to deplete glutathione availability sensitizes the 
MCF-7 cells to IR-induced damage resulting in G1 cell cycle 
arrest, greater DNA damage and reduced cell viability.
Interestingly, PEITC did not deplete MCF-10A cells 
of glutathione and these cells were also less sensitive to 
PEITC-induced DNA damage. PEITC has previously been 
shown to selectively kill cancer cells over non-tumorigenic 
cell lines due to their lower antioxidant status [36–38]. When 
MCF-10A cells were exposed to IR and PEITC (10 µM), 
glutathione was depleted as it scavenges IR-derived ROS 
and to compensate for this loss glutathione synthesis was 
up-regulated. This metabolic adaption may explain the lower 
DNA damage seen in MCF-10A cells compared to MCF-7 
cells following IR.
Cellular membranes are a primary target of IR due 
to the impact ROS can have on lipid bilayers, of which 
Fig. 5  Unsupervised hierarchical clustering heat-map of metabolites 
from MCF-7 (a) and MCF-10A (b) cells treated with watercress 
extract or PEITC at increasing concentrations. Each row represents 
a metabolite and each column represents a sample. The row Z score 
(scaled expression value) of each metabolite is plotted in red–blue 
colour. The red colour indicates metabolites that are high in abun-
dance and blue indicates metabolites low in abundance
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phosphocholine is a main constituent. Following IR, phos-
phocholine was increased in the MCF-10A cells. This 
increase may reflect the efforts of the cell to maintain mem-
brane integrity, which is violated by ROS produced during 
IR. This is consistent the greater abundance of glutathione 
in MCF-10A cells and their greater resistance against oxida-
tive damage. Conversely, phosphocholine was reduced in the 
MCF-7 cells in response to IR. Decreases in phosphocho-
line have been observed in tissues after chemotherapy and 
radiation treatment and have been correlated with positive 
therapy outcomes [32, 39–41].
In both cell types, the watercress extract increased the 
cellular glutathione content. This is likely to be a result 
of the complex mixture of compounds in the watercress 
extract such as phenolics and flavonoids with proven anti-
oxidant properties. Flavonoids increase the expression of 
γ-glutamylcysteine synthetase, which is directly propor-
tional to glutathione abundance [42]. Watercress is also a 
rich source of folate [43] which can be used in one-carbon 
metabolism pathway, adding to the cellular glutathione pool. 
Several in vitro studies have shown the anti-genotoxic prop-
erties of watercress extracts [10, 44]. In the MCF-10A cells, 
pre-treatment with the watercress extract had a protective 
effect against IR exposure, evidenced by lower DNA dam-
age compared to MCF-7 cells additional to increased glu-
tathione content. This suggests enhanced antioxidant activity 
and hence a protective effect. The presence of additional 
antioxidant compounds in watercress help to preserve the 
glutathione content of the cells.
PEITC and watercress strongly interact with the metabo-
lism of amino acids in both cell lines. PEITC at the higher 
doses, but not watercress, induced a strikingly selective 
increase in the pool of amino acids in MCF-7 cells, but not 
in the MCF-10A cells. These effects were generally main-
tained after IR. Rapidly dividing cells rely heavily on the 
maintenance of their biosynthetic potential as well as redox 
status for survival. Continuous shuttling of carbon molecules 
through amino acids such as glycine, methionine, threonine 
and serine, in the one-carbon metabolism pathway, which 
has a central role in cell proliferation and cancer progression, 
ensures the availability of the building blocks necessary for 
the construction of new cellular components. This also sus-
tains the formation of reducing power compounds for redox 
balance. Accumulation of amino acids in the PEITC-treated 
MCF-7 cells is suggestive of a blockage in one-carbon 
metabolism pathway resulting in the inability of these cells 
to maintain their needs in macromolecules necessary for 
proliferation, increasing their susceptibility to IR damage.
Amino acids are key components for the protein transla-
tional requirements of cancer cells. Elevated mRNA transla-
tion is a key driver of carcinogenesis and PEITC has been 
recently shown to increase eIF2a phosphorylation and inhibit 
mTORC1 activity resulting in inhibition of translation in 
MCF-7 cells and in B cells from chronic lymphocytic leu-
kaemia [45]. Further investigation is needed to understand if 
the accumulation of amino acids seen in the PEITC-treated 
cells is a cause or consequence of translational inhibition.
mTORC1 is master regulator of protein translation, which 
is a known target of PEITC [46, 47]. PEITC causes mito-
chondrial damage that essentially increases the AMP/ATP 
ratio due to energy depletion, which in turn activates AMPK. 
AMPK acts upstream of mTORC1, ultimately inactivating 
it and suppressing translation. MCF-10A cells have a lower 
basal mTORC1 activity as compared to the MCF-7 cells [48] 
suggesting that PEITC has a stronger affinity for cells with 
increased rates of translation.
The chemopreventive potential of watercress and its 
effects against oxidative stress have been investigated in a 
number of in vivo studies. Although pharmacokinetic data 
for PEITC following the ingestion of watercress is limited, 
Ji et al. reported a mean maximal PEITC plasma concentra-
tion (Cmax) of 929 nM following the consumption of 100 g 
of watercress [49] while Alwi et al. [50] reported a Cmax of 
297 nM with 80 g watercress. In the study by Alwi et al., this 
single 80 g of portion of watercress was sufficient to reduce 
the phosphorylation of 4E-binding protein 1, a key factor 
in angiogenesis. In another study, a single 50 g portion of 
watercress effectively attenuated the immunoreactivity of 
a proinflammatory cytokine macrophage migration inhibi-
tory factor [51]. Daily intake of 85 g of watercress for 8 
weeks has been shown to decrease DNA damage in periph-
eral blood lymphocytes and lipid peroxidation [8, 9] These 
in vivo studies demonstrate that dietary intake of watercress 
is sufficient to modulate anticarcinogenic pathways.
Conclusions
These results suggest a potential synergistic effect of PEITC 
and IR towards MCF-7 cell killing and radiosensitization 
and that watercress extract, free of PEITC, can rescue 
healthy cells from collateral damage. It is postulated that 
glutathione has a principle role in the response of cells to IR 
challenge and that the inclusion of dietary watercress dur-
ing RT may enhance the outcome. The systemic impact of 
watercress against breast cancer should be further explored 
in the clinical setting, as well as the response of the breast 
cell lines to IR following treatment with a combination of 
Fig. 6  Summary of metabolic perturbations induced in MCF-7 (a) 
and MCF-10A (b) cells treated with the watercress extract or PEITC 
and IR. Green triangles indicate WX treatment and red triangles indi-
cate treatment with PEITC. Dotted-lined triangles indicated IR expo-
sure following WX or PEITC treatment
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the watercress extract and PEITC, for the generation of 
robust evidence in support of the current findings.
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